How does cancer cell metabolism affect tumor migration and invasion?

被引:165
作者
Han, Tianyu [1 ]
Kang, De [1 ]
Ji, Daokun [1 ]
Wang, Xiaoyu [1 ]
Zhan, Weihua [1 ]
Fu, Mingui [1 ]
Xin, Hong-Bo [1 ]
Wang, Jian-Bin [1 ]
机构
[1] Nanchang Univ, Inst Translat Med, Nanchang, Jiangxi, Peoples R China
关键词
cancer cell metabolism; cell migration; metastasis; glycolysis; glutamine; AUTOCRINE MOTILITY FACTOR; KINASE TYPE M2; NF-KAPPA-B; MESENCHYMAL TRANSITION; AEROBIC GLYCOLYSIS; ENERGY-METABOLISM; FUMARATE-HYDRATASE; GLIOMA MIGRATION; EXTRACELLULAR PH; PATIENT SURVIVAL;
D O I
10.4161/cam.26345
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cancer metastasis is the major cause of cancer-associated death. Accordingly, identification of the regulatory mechanisms that control whether or not tumor cells become "directed walkers" is a crucial issue of cancer research. The deregulation of cell migration during cancer progression determines the capacity of tumor cells to escape from the primary tumors and invade adjacent tissues to finally form metastases. The ability to switch from a predominantly oxidative metabolism to glycolysis and the production of lactate even when oxygen is plentiful is a key characteristic of cancer cells. This metabolic switch, known as the Warburg effect, was first described in 1920s, and affected not only tumor cell growth but also tumor cell migration. In this review, we will focus on the recent studies on how cancer cell metabolism affects tumor cell migration and invasion. Understanding the new aspects on molecular mechanisms and signaling pathways controlling tumor cell migration is critical for development of therapeutic strategies for cancer patients.
引用
收藏
页码:395 / 403
页数:9
相关论文
共 111 条
[71]   Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review [J].
Porporato, Paolo E. ;
Dhup, Suveera ;
Dadhich, Rajesh K. ;
Copetti, Tamara ;
Sonveaux, Pierre .
FRONTIERS IN PHARMACOLOGY, 2011, 2
[72]   Hypoxia signalling in cancer and approaches to enforce tumour regression [J].
Pouyssegur, Jacques ;
Dayan, Frederic ;
Mazure, Nathalie M. .
NATURE, 2006, 441 (7092) :437-443
[73]   The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate [J].
Riganti, Chiara ;
Gazzano, Elena ;
Polimeni, Manuela ;
Aldieri, Elisabetta ;
Ghigo, Dario .
FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (03) :421-436
[74]   Glutamate antagonists limit tumor growth [J].
Rzeski, W ;
Ikonomidou, C ;
Turski, L .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (08) :1195-1200
[75]   A Δ38 Deletion Variant of Human Transketolase as a Model of Transketolase-Like Protein 1 Exhibits No Enzymatic Activity [J].
Schneider, Stefan ;
Luedtke, Stefan ;
Schroeder-Tittmann, Kathrin ;
Wechsler, Cindy ;
Meyer, Danilo ;
Tittmann, Kai .
PLOS ONE, 2012, 7 (10)
[76]   TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens [J].
Schultz, Holger ;
Kaehler, Daniel ;
Branscheid, Detlev ;
Vollmer, Ekkehard ;
Zabel, Peter ;
Goldmann, Torsten .
DIAGNOSTIC PATHOLOGY, 2008, 3 (1)
[77]  
SEMENZA GL, 1994, J BIOL CHEM, V269, P23757
[78]   Targeting HIF-1 for cancer therapy [J].
Semenza, GL .
NATURE REVIEWS CANCER, 2003, 3 (10) :721-732
[79]   Polarization of chemoattractant receptor signaling during neutrophil chemotaxis [J].
Servant, G ;
Weiner, OD ;
Herzmark, P ;
Balla, T ;
Sedat, JW ;
Bourne, HR .
SCIENCE, 2000, 287 (5455) :1037-1040
[80]   Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells [J].
Shen, S. H. ;
Kwan, A. L. ;
Chen, Y. Y. ;
Wang, Z. X. .
NEUROLOGICAL SCIENCES, 2013, 34 (03) :365-371